Literature DB >> 9323562

Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy.

J Marin-Garcia1, R Ananthakrishnan, M J Goldenthal, J J Filiano, A Perez-Atayde.   

Abstract

Abnormalities in specific mitochondrial respiratory enzymes and DNA (mtDNA) have been reported in cardiomyopathy. In this study, we report 4 cases of severe hypertrophic cardiomyopathy (HCM) in which specific cardiac mitochondrial enzyme activity defects were found, including complex I (n = 2), complex III (n = 2), complex IV (n = 2) and complex V (n = 1). Other abnormalities were also noted including a marked depletion of mtDNA (n = 1) and decreased content of subunit 2 of cytochrome c oxidase (n = 1). None of the mtDNA point mutations and common deletions previously found in association with cardiomyopathy were detected in these patients. These data indicate that specific respiratory enzyme activity defects are frequently present in HCM. Also, our finding of a marked depletion of mtDNA in 1 patient suggests that cardiac mtDNA depletion, previously unreported in HCM, needs further examination in order to establish whether it plays a primary role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323562     DOI: 10.1023/a:1005322409330

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  Mitochondrial mutation in fatal infantile cardiomyopathy.

Authors:  M Tanaka; H Ino; K Ohno; K Hattori; W Sato; T Ozawa; T Tanaka; S Itoyama
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

2.  Dilated cardiomyopathy in a zidovudine-treated AIDS patient.

Authors:  G d'Amati; W Kwan; W Lewis
Journal:  Cardiovasc Pathol       Date:  1992 Oct-Dec       Impact factor: 2.185

3.  Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR).

Authors:  M Zeviani; C Gellera; C Antozzi; M Rimoldi; L Morandi; F Villani; V Tiranti; S DiDonato
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

4.  A novel mtDNA point mutation in maternally inherited cardiomyopathy.

Authors:  C Casali; F M Santorelli; G D'Amati; P Bernucci; L DeBiase; S DiMauro
Journal:  Biochem Biophys Res Commun       Date:  1995-08-15       Impact factor: 3.575

5.  Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies.

Authors:  P Rustin; J Lebidois; D Chretien; T Bourgeron; J F Piechaud; A Rötig; A Munnich; D Sidi
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

Review 6.  Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G).

Authors:  G M Pastores; F M Santorelli; S Shanske; B D Gelb; B Fyfe; D Wolfe; J P Willner
Journal:  Am J Med Genet       Date:  1994-04-15

7.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors:  R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy.

Authors:  M Zeviani; C Mariotti; C Antozzi; G M Fratta; P Rustin; A Prelle
Journal:  Muscle Nerve Suppl       Date:  1995

9.  A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy.

Authors:  G Silvestri; F M Santorelli; S Shanske; C B Whitley; L A Schimmenti; S A Smith; S DiMauro
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

10.  Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome.

Authors:  J Poulton; C Sewry; C G Potter; T Bougeron; D Chretien; F A Wijburg; K J Morten; G Brown
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

View more
  5 in total

Review 1.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 2.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children.

Authors:  J Marin-Garcia; R Ananthakrishnan; M J Goldenthal; M E Pierpont
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

Review 4.  Mitochondrial DNA maintenance: an appraisal.

Authors:  Alexander T Akhmedov; José Marín-García
Journal:  Mol Cell Biochem       Date:  2015-08-19       Impact factor: 3.396

Review 5.  Mitochondrial DNA repair: a novel therapeutic target for heart failure.

Authors:  José Marín-García
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.